Breaks Categories: News

WednesdaySep 30, 2026 11:06 am

NetworkNewsBreaks – Stocktwits Announces Stocktoberfest 2026 in New York City Oct. 5-7

Stocktwits announced that its flagship Stocktoberfest 2026 event will be held Oct. 5-7 at locations across New York City, with Tradr ETFs serving as title partner. The two-and-a-half-day conference expects more than 300 attendees and will feature more than 40 speakers across keynotes, panels and fireside chats focused on topics including market signals, trading strategies, corporate strategy, retail investor education, agentic trading and investing and the evolving financial media landscape. Programming will bring retail investors together with public company executives, economists, analysts, investment professionals and financial content creators. Stocktoberfest will include golf and networking at Century Country Club, comedy and…

Continue Reading

WednesdaySep 30, 2026 10:55 am

NetworkNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) to Present at AI & Technology Virtual Investor Conference Oct. 1 

Perpetuals.com (NASDAQ: PDC) an AI-powered financial services company, announced that Chief Strategy Officer and Director Matthew Nicoletti will present live at the AI & Technology Virtual Investor Conference on Oct. 1, 2026. The interactive online event will allow investors to ask questions in real time, with an archived webcast available afterward. To view the full press release, visit https://nnw.fm/mmODZ About Perpetuals Perpetuals.com Ltd (NASDAQ: PDC) is a fintech company developing AI-powered trading products and prediction markets, with a global footprint across the United States, Europe, and Asia. Its mission is to reduce risk by empowering retail users with intuitive, secure,…

Continue Reading

WednesdaySep 30, 2026 10:39 am

NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Co-Founder Discusses Lucid-MS Phase 2 Program, unbuzzd(TM) in BioMedWire Podcast

Quantum BioPharma (NASDAQ: QNTM) Co-Founder and Executive Co-Chair Anthony Durkacz returned to The BioMedWire Podcast to discuss the company’s Lucid-MS drug candidate, which is advancing to a Phase 2 trial in multiple sclerosis patients, as well as the development and commercial opportunity surrounding unbuzzd(TM). Durkacz said Lucid-MS targets myelin and that the upcoming trial will mark the first time the drug is tested in patients with multiple sclerosis. He also highlighted clinical results for unbuzzd(TM), which is designed to accelerate alcohol metabolism, and said Quantum BioPharma owns approximately 20% of the company behind the product and has a 7% royalty…

Continue Reading

WednesdaySep 30, 2026 10:20 am

NetworkNewsBreaks – Quarterhill Inc. (TSX: QTRH) (OTCQX: QTRHF) Secures $60 Million Credit Facility With $100 Million Accordion

This article has been disseminated on behalf of Quarterhill Inc. and may include paid advertising. Quarterhill (TSX: QTRH) (OTCQX: QTRHF) secured a $60 million senior secured credit facility with U.S. Private Credit Investments (“PCI”), a division of BTG Pactual Global Alternatives, with Roth Canada serving as co-lead debt advisor. The financing consists of a $30 million initial term loan facility, a $25 million delayed draw term loan facility and a $5 million revolving credit facility. Proceeds will be used to repay obligations under Quarterhill’s existing credit agreement, redeem its convertible debentures, pay transaction fees and expenses and provide working capital.…

Continue Reading

WednesdaySep 30, 2026 9:20 am

NetworkNewsBreaks – BTQ Technologies Corp. (NASDAQ: BTQ) (CBOE CA: BTQ) Signs Three-Year Commercial Agreement to Deploy QSSN Across Kaia Blockchain

This article has been disseminated on behalf of BTQ Technologies Corp. and may include paid advertising. BTQ (NASDAQ: BTQ) (CBOE CA: BTQ) signed a three-year commercial agreement with Kaia DLT Foundation to deploy its Quantum Secure Stablecoin Network (“QSSN”) across the Kaia blockchain ecosystem, marking QSSN’s first recurring commercial deployment. BTQ will receive a portion of transaction fees generated by QSSN-secured activity and expects first-year revenue in the six figures, with revenue over the three-year term tied to transaction volume. QSSN will provide account-level protection for stablecoins on Kaia, extending across its transaction and settlement infrastructure and applications built on…

Continue Reading

WednesdaySep 30, 2026 9:00 am

NetworkNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Further Amends Articles Resolution, Extends Proxy Voting Deadline

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) approved a further variation to the special resolution concerning proposed amendments to its Articles ahead of its Oct. 2, 2026, annual general and special meeting of shareholders. The latest change removes the company ability to request information about a proposed director nominee beyond information specifically enumerated in Article 16, paragraph 4. Silvercorp extended the proxy voting deadline to Sept. 30, 2026, at 4 p.m. Pacific time. To view the full press release, visit https://nnw.fm/HkGHo About Silvercorp Silvercorp is…

Continue Reading

TuesdaySep 29, 2026 11:11 am

NetworkNewsBreaks – American Fusion Inc. (OTC: AMFN) Completes Technical Analysis of Texatron Fusion Engine 

American Fusion (OTC: AMFN) announced that Chief Technology Officer Dr. John E. Brandenburg completed a technical analysis describing the proposed plasma-formation, compression and confinement approach underlying the company proprietary Texatron (TM) Fusion Engine (TM). The analysis outlines a theoretical framework in which a powerful magnetic pulse compresses plasma within a rifled toroidal chamber, with the goal of achieving the temperature, density and confinement required for fusion. American Fusion said its current testing focuses on consistently producing plasma and measuring temperature, density, magnetic-field strength, compression and confinement while evaluating the effects of chamber geometry on plasma behavior. Texatron (TM) is being…

Continue Reading

TuesdaySep 29, 2026 11:02 am

NetworkNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary, MindWave Innovations, Signs 12-Month Agreement to Build FlashChain 

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc., signed a 12-month software development and technology services agreement with Flash Sports & Media Holdings, Inc. to build and operate FlashChain, a blockchain designed to track digital broadcasting rights, video assets and match ticket inventory. MindWave will deploy a dedicated FlashChain subnet on its MindChain Layer-2 infrastructure, operate validator nodes and develop software connecting Flash streaming and ticketing platforms and gate-scanning hardware to the network. Under the agreement, MindWave will also develop smart contracts to authenticate digital match tickets, manage digital sports memorabilia and…

Continue Reading

TuesdaySep 29, 2026 9:40 am

NetworkNewsBreaks – Xeriant, Inc. (OTCQB: XERI) Reports Nearly 25% Weight Reduction in NexBoard Production

Xeriant (OTCQB: XERI) provided an update on ongoing production of NexBoard (TM) at its contract manufacturer, reporting that the company achieved nearly a 25% reduction in panel weight while maintaining the same dimensions. Xeriant said the manufacturing process is being used to establish material compatibility, equipment capabilities, cycle times and product consistency as it prepares for future production scaling. Production is continuing as Xeriant works through additional product objectives, with panels being used to fulfill sample requests from homebuilders and commercial construction firms evaluating NexBoard (TM) as a universal construction panel. Marketed under the DUREVER (TM) brand, NexBoard (TM) is…

Continue Reading

TuesdaySep 29, 2026 9:30 am

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Announces $4 Million Registered Direct Offering

Lantern Pharma (NASDAQ: LTRN) announced a definitive agreement for the purchase and sale of 3,669,725 shares of common stock, or pre-funded warrants in lieu thereof, at $1.09 per share in a registered direct offering expected to generate approximately $4 million in gross proceeds. In a concurrent private placement, the company will issue unregistered warrants to purchase up to 3,669,725 additional shares at an exercise price of $1.09 per share, potentially generating approximately $4 million in additional gross proceeds if fully exercised for cash. The offering is expected to close on or about Sept. 30, 2026, subject to customary closing conditions,…

Continue Reading